Presentation is loading. Please wait.

Presentation is loading. Please wait.

Upper row shows myocardial infarction with MVO (−IMH) (indicated by arrows) on pathology (A), T2-STIR (B), late gadolinium enhancement (LGE) images (C)

Published byRitva Siitonen Modified over 5 years ago

Similar presentations

Presentation on theme: "Upper row shows myocardial infarction with MVO (−IMH) (indicated by arrows) on pathology (A), T2-STIR (B), late gadolinium enhancement (LGE) images (C)"— Presentation transcript:

1 Upper row shows myocardial infarction with MVO (−IMH) (indicated by arrows) on pathology (A), T2-STIR (B), late gadolinium enhancement (LGE) images (C) and T1W IR (D). Upper row shows myocardial infarction with MVO (−IMH) (indicated by arrows) on pathology (A), T2-STIR (B), late gadolinium enhancement (LGE) images (C) and T1W IR (D). Lower row shows myocardial infarction with MVO (+IMH) (indicated by arrows) on pathology (E), T2-STIR (F) and LGE images (G), and T1W IR (H). IMH, intramyocardial haemorrhage; MVO, microvascular obstruction; T2-STIR, T2 weighted short tau inversion recovery. Esben Søvsø Szocska Hansen et al. Open Heart 2016;3:e000346 ©2016 by British Cardiovascular Society

Download ppt "Upper row shows myocardial infarction with MVO (−IMH) (indicated by arrows) on pathology (A), T2-STIR (B), late gadolinium enhancement (LGE) images (C)"

Similar presentations

“How we do” CMR in acute myocardial infarction Derek J Hausenloy, Anna S Herrey, James C Moon UCLH Heart Hospital and The Hatter Institute, University.

“How we do” CMR in acute myocardial infarction Derek J Hausenloy, Anna S Herrey, James C Moon UCLH Heart Hospital and The Hatter Institute, University.
“How we do” CMR in acute myocardial infarction

“How we do” CMR in acute myocardial infarction
Maude Pagé, MD, Agata E. Grasso, MD, John-Paul Carpenter, MD, Mary N

Maude Pagé, MD, Agata E. Grasso, MD, John-Paul Carpenter, MD, Mary N
Three cases illustrating the importance of the endocardial extent of infarction and its location for the QRS score. A. A small transmural, non–Q wave myocardial.

Three cases illustrating the importance of the endocardial extent of infarction and its location for the QRS score. A. A small transmural, non–Q wave myocardial.
Fig year-old girl with juvenile rheumatoid arthritis

Fig year-old girl with juvenile rheumatoid arthritis
Myocarditis Associated With Campylobacter Enteritis: Report of Three Cases by Dries De Cock, Nick Hiltrop, Philippe Timmermans, Steven Dymarkowski, and.

Myocarditis Associated With Campylobacter Enteritis: Report of Three Cases by Dries De Cock, Nick Hiltrop, Philippe Timmermans, Steven Dymarkowski, and.
Figure 10 Assessment of myocardial fibrosis

Figure 10 Assessment of myocardial fibrosis
Figure 3 T1 mapping and late gadolinium enhancement (LGE)

Figure 3 T1 mapping and late gadolinium enhancement (LGE)
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)

Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)
Alexander Liu et al. JACC 2018;71:

Alexander Liu et al. JACC 2018;71:
Francisco Leyva et al. JACC 2017;70:

Francisco Leyva et al. JACC 2017;70:
Figure Facial photograph during headache attack and brain and upper cervical cord MRI Facial photograph during headache attack and brain and upper cervical.

Figure Facial photograph during headache attack and brain and upper cervical cord MRI Facial photograph during headache attack and brain and upper cervical.
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.
Flow chart of the study population according to thienopyridines used in the FAST-MI registry in patients with STEMI and NSTEMI. FAST-MI, French Registry.

Flow chart of the study population according to thienopyridines used in the FAST-MI registry in patients with STEMI and NSTEMI. FAST-MI, French Registry.
Masashi Maeda et al. Heart Asia 2013;5:7-14

Masashi Maeda et al. Heart Asia 2013;5:7-14
Brain and spine MR imaging of a 48-year-old woman with Zika virus infection and encephalitis and myelitis. Brain and spine MR imaging of a 48-year-old.

Brain and spine MR imaging of a 48-year-old woman with Zika virus infection and encephalitis and myelitis. Brain and spine MR imaging of a 48-year-old.
(A) Image of a stent that was damaged withdrawing it back into a Guideliner V2 after failing to cross the lesion. (A) Image of a stent that was damaged.

(A) Image of a stent that was damaged withdrawing it back into a Guideliner V2 after failing to cross the lesion. (A) Image of a stent that was damaged.
HOMA calculations where glucose is mmol/L and insulin is mU/L

HOMA calculations where glucose is mmol/L and insulin is mU/L

Similar presentations

Ads by Google